1Scientific evaluation of safety and efficacy of an herbal formulation (RAI) in the rheumatioid arthritis.Dr. Hannah Rachel Vasanthi, Assistant Professor, Department of BiochemistryEID PARRY 20097.21
2Monitoring and evaluation of improved cook stove in South India Dr. S. Sankar, Department of Environmental Health EngineeringSHELL Foundation, USA 200915.00
3Development, standardization and safety of a poly herbal formulation in the management of OBESITY Associated Hyperlipidemia Dr.Venkatesh, Veterinary OfficerDST/Arvind Remedies 3 years200995.102
4To examine the minimum inhibitory concentrations pf PLSL’s samples against SRU’s 35 clinical and susceptible strainsDr.Uma Sekar Dept of MicrobiologyPiramal Life Sceinces Ltd1 year20094.20
5Retrospective Chart Analysis of Subjects with a History of Threatened Abortion / Miscarriage, S 102.3.120Dr. Jaya VijayaraghavanSolvay Pharmaceuticals GmbH / Quintiles Research (India) Private Limited 20090.32
6A Phase IV multicentric, rnadomized, comparative clinical trial to assess the immunogenicity and reactogenicity of the different lots of DTwPHB+Hib (pentavac) vaccine manufactured by Serum Institute of India Ltd., Pune in indian infants".Dr. Latha RavichandranSerum Institute of India Ltd 20098.92
7Efficacy and safety of two fixed doses (160 or 320 mg/day) of Ralfinamide in patients with chronic neuropathic low back pain. A multicenter, Double-blind, randomized, placebo-controlled 12-week study longterm extension (Protocol No.NW-1029/01-08)Dr. C.U.VelmurugendranNewron S.P.A / CliniRx Research Pvt. Ltd. 20091.30
8PGL07-021 (PEARL I) " A Phase III, Randomized, Parallel group, Double-Blind, Placebo - controlled, Multi-center study to assess the efficacy and safety of PGL4001 (ulipristal) versus placebo for pre - operative treatment of symptomatic uterine myomas"Dr. Jaya VijayaraghavanPregLem S. A Chemin / ICON Clinical Research India Private Limited 20091.01
9A Multinational, multicenter, randomized, double blind study comparing the efficacy and safety of AVE5026 with enoxaparin for the Prevention of Venous Thromboembolism (VTE) in patients undergoing Major Abdominal Surgery PC: 20379Dr. A. RaviSanofi-aventis Recherche & Development / ICON Clinical Research India Private Limited 20090.95
10A Multicenter, Double-blind, Randomized, Parallel-group, and Placebo controlled study to determine the clinical bioequivalence of a generic clotrimazole 1% and Betamethasone Dipropionate 0.05% Topical Cream and the reference listed Lotrisone® (Clotrimazole 1% and Betamethasone Dipropionate 0.05%) Topical Cream in subjects with Inderdigital Tinea PedisDr. S. AnandanGlenmark Generics Ltd / SIRO Clinpharm Pvt. Ltd 20090.018
Page 1 of 4 (33 items)